Besifloxacin

Overview

Besifloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201760).

API suppliers (1)

Suppliers of Besifloxacin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• RUYUAN HEC PHARM CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Besifloxacin expires 9 Jan 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

Canonical SMILES

C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F

InChIKey

QFFGVLORLPOAEC-SNVBAGLBSA-N